Résultats de recherche
Il y a 5 jours · Drew Weissman est professeur dans le domaine de la recherche sur les vaccins et directeur du Penn Institute for RNA Innovation. Il est professeur au département de médecine et directeur de la recherche sur les vaccins à la division des maladies infectieuses de la Perelman School of Medicine de l’Université de Pennsylvanie.
Il y a 5 jours · Professor Katalin Karikó (pictured) and Professor Drew Weissman of the University of Pennsylvania, was awarded for their outstanding contributions to the development of mRNA vaccines for COVID-19 at the opening of the World Health Assembly on 27 May 2024.
Il y a 3 jours · Building upon this foundation, Katalin Karikό and Drew Weissman discovered, in early 2000, that the incorporation of modified nucleosides into mRNA could mitigate its intrinsic immunostimulatory activity while preserving translation efficiency.
Il y a 2 jours · mRNA vaccine by UPenn scientists could manage bird flu outbreak. Researchers led by Scott Hensley of the Perelman School of Medicine have collaborated with Drew Weissman to develop an mRNA vaccine to treat the H5N1 avian flu. May 30, 2024 ・ From The Hill. If there’s news at Penn, you’ll find it here. We strive to bring you faculty, staff ...
Il y a 4 jours · Professor Katalin Karikó and Professor Drew Weissman of the University of Pennsylvania for their outstanding contributions to the development of mRNA vaccines for COVID-19 at the opening of the Health Assembly. H.E. Mia Mottley, Prime Minister of Barbados, received her award at the Launch of WHO Investment Round event on Sunday, 26 May.
Il y a 1 jour · As for the vaccine for cows, Penn immunologist Scott Hensley worked with mRNA pioneer and Nobel laureate Drew Weissman to produce the experimental doses. Hensley said that vaccine is similar to ...
Il y a 2 jours · Hensley and his laboratory collaborated with Drew Weissman, a professor and director of vaccine research at Penn Medicine, and his lab, to conduct this research. Weissman said before 2020, experts had limited options for creating a vaccine. However, the COVID-19 pandemic showed scientists the “power of mRNA-based vaccines as tool to protect humans from emerging viruses quickly,” Weissman said.
